Resitu: minimally invasive surgical technology

Elisabeth Liljensten

Elisabeth Liljensten has over 20 years of experience in clinical and preclinical development in medical devices. She founded Devicia AB/Inc and has held several director roles in Swedish and US medical device companies. Elisabeth has been chair of MEDEA, a Swedish branch organization for consultants in medical technology. She is an expert in ISO standards, governing the conduct of clinical investigations.

Published 2022-05-04


Resitu Medical AB
Rapsgatan 7B
Uppsala, Sweden

Resitu Medical AB is a Swedish Medical Device company founded in 2019. The company is developing instruments enabling safe removal of intact tissues by a revolutionary technology. The solution has the potential to create a paradigm shift in the management of breast cancer. The portfolio of instruments will speed up the process of cancer management using a minimally invasive approach and facilitating the way radiologists and surgeons work.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.